Business
CareDx Announces Appointment of Nathan Smith as Chief Financial Officer
BRISBANE, Calif., August 06, 2025--CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the appointment of Nathan Smith to the role of Chief Financial Officer. Nathan will lead key financial and accounting initiatives that are a part of the Company’s long-term strategic growth pl
About this update from Myriad Genetics, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":8000,"height":2250,"url":"https://media.zenfs.com/en/business-wire.com/551c07ec8580a99aa774753be9ee2b26"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/xTlEq0CM_3xWq019YHtT1Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI3MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/551c07ec8580a99aa774753be9ee2b26","width":960,"height":270},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/EnJWgd7tKrWX0ktdVBqDiQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD02NzY7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/551c07ec8580a99aa774753be9ee2b26","width":1200,"height":338}},"lazy":false},{"type":"text","content":"BRISBANE, Calif., August 06, 2025--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the appointment of Nathan Smith to the role of Chief Financial Officer. Nathan will lead key financial and accounting initiatives that are a part of the Company’s long-term strategic growth plan.","length":520,"tagName":"p"},{"type":"text","content":"Nathan brings more than 14 years of experience in the molecular diagnostics industry, including senior finance leadership roles at Myriad Genetics and recent CFO positions at Blackrock Neurotech and WIN Brands.","length":210,"tagName":"p"},{"type":"text","content":""Nathan’s deep financial expertise in molecular diagnostics is a great fit for CareDx," said John Hanna, CEO of CareDx. "His track record of operational excellence and experience in supporting diagnostics companies to scale efficiently will be invaluable as we enter our next phase."","length":303,"tagName":"p"},{"type":"text","content":"In conjunction with this appointment, the Company also announced that Abhishek Jain will be retiring from his role as Chief Financial Officer. Abhishek will continue to support CareDx in a consulting capacity to ensure a seamless transition.","length":241,"tagName":"p"},{"type":"text","content":""On behalf of the Board and the entire CareDx team, I want to express my sincere gratitude to Abhishek for his outstanding...